Hadassah

Hadassah Shares Breakthroughs at Annual World Stem Cell Summit

Thursday, Jan 5 2017

Left to right: Prof. Raphael Gorodetsky, head of Hadassah’s Biotechnology and Radiobiology Laboratory in the Sharett Institute of Oncology; Stewart Greenberg, Hadassah melanoma patient; Diane Issenberg, Hadassah Chair of Development; Malia Litman, multiple sclerosis patient; and Hadassah Senior Neurologist Prof. Dimitrios Karussis at the World Stem Cell Summit in Florida.

At the recent 12th Annual World Stem Cell Summit in West Palm Beach Florida, Hadassah Medical Organization Senior Neurologist Prof. Dimitrios Karussis and his patient, Malia Litman, shared their personal, groundbreaking stem cell success stories in treating neurodegenerative diseases, such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Prof. Raphael Gorodetsky, PhD, head of Hadassah’s Biotechnology and Radiobiology Laboratory at the Sharett Institute of Oncology, gave a presentation about his scientific research aimed at developing new techniques for cell-based therapies, which has led to a placental stem cell product to treat acute radiation syndrome.

Prof. Karussis reported on his latest ALS clinical trial in which 87 percent of the patients responded positively to the treatment--either in terms of respiratory function or general motor ability, with no serious adverse effects. "I believe we are in the early stages of something new and revolutionary with this harvested stem cell infusion therapy,” related Prof. Karussis. “While this is absolutely by no means a cure for these neurodegenerative diseases, it is the first step in a long process which we anticipate will lead to a cure.”

Ms. Litman explained how just three stem cell treatments brought her tremendous physical improvement. For example, she said, she was able to host 31 people for Thanksgiving, including doing cooking and baking herself, whereas before she was treated, she would have to take a nap after exerting any energy--even doing something small like taking a shower. She is now a leading stem cell research activist.

In his presentation, “Innovative Cell Therapies and Translational Studies,” Prof. Gorodetsky reported that “some of our recently innovative techniques have already been proven and are being used by Pluristem Therapeutics (a leading Israeli cell therapy company) in Food and Drug Administration-approved clinical studies worldwide.” The product, entitled PLX-R18 and developed by Pluristem based on Prof. Gorodetsky’s basic science research, is a placental-cell based therapy to mitigate acute radiation syndrome (ARS) as well as enhance bone marrow regeneration following a bone marrow transplant.

Hundreds of Hadassah members from around the Tri-County area attended to hear about Hadassah’s latest research firsthand and to support Hadassah, which was an educational partner for the Summit. The annual event is a project of the nonprofit Regenerative Medicine Foundation, whose mission is “to accelerate regenerative medicine to improve health and deliver cures.”

During Hadassah’s special private Briefing Session, Stewart Greenberg, a stage-four melanoma patient of Dr. Michal Lotem, head of Hadassah’s Center for Melanoma and Cancer Immunotherapy, spoke about his acceptance into a personally tailored melanoma vaccine clinical trial. The immunotherapy treatments, he related, gave him a new lease on life when other doctors could offer him no hope.

Offering his audience a dose of optimism, Prof. Karussis, in explaining his stem cell protocol, said: "I see this treatment as being one of the major future tools to treat degenerative diseases of the brain and spinal cord. I am confident that within the next three to five years, we may provide a treatment to patients that can stop the progression of these diseases and induce some kind of recovery."

Read more about Malia and Prof. Karussis and how Hadassah is leading the way in stem cell research.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Feb 20 2018

Nursing Students Spark Change in ER Experience for Challenged Patients

A physically, cognitively, and emotionally challenged middle-aged man was brought to the Hadassah Hospital Ein Kerem Emergency Room (ER) from the Israel Elwyn residential community, where he has lived for decades.

READ MORE ›
alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More